HOMEVULNERABILITIESCVE-2020-16208
HIGH

CVE-2020-16208

CWE-352Published: September 1, 2020· Updated: Jun 17, 2026

8.8
CVSS v3.1

Official Description

The affected product is vulnerable to cross-site request forgery, which may allow an attacker to modify different configurations of a device by luring an authenticated user to click on a crafted link on the N-Tron 702-W / 702M12-W (all versions).

NVD Source

Technical Analysis

CVE-2020-16208 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation does not require any privileges, though user interaction (Required) is needed, which slightly reduces the risk of mass automated attacks.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 8.8.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionRequired
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Affected Vendors & Products

redlion4 product(s)
n-tron 702-w firmwaren-tron 702-wn-tron 702m12-w firmwaren-tron 702m12-w
Source: NVD CPE · 4 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (6)

Quick Facts

CVE IDCVE-2020-16208
CVSS Score8.8 / 10
SeverityHIGH
WeaknessCWE-352
CISA KEVNo
Affected1 vendor(s)
PublishedSep 1, 2020

Related CVEs (CWE-352)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2020-16208 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.